Clearline Capital LP bought a new position in shares of Acadia Healthcare Company Inc (NASDAQ:ACHC) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 89,992 shares of the company’s stock, valued at approximately $2,936,000. Acadia Healthcare accounts for about 1.5% of Clearline Capital LP’s portfolio, making the stock its 18th largest position. Clearline Capital LP owned approximately 0.10% of Acadia Healthcare as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also recently bought and sold shares of the company. State of Alaska Department of Revenue bought a new stake in Acadia Healthcare during the 4th quarter worth approximately $150,000. Tyers Asset Management LLC grew its stake in Acadia Healthcare by 31.8% in the 4th quarter. Tyers Asset Management LLC now owns 5,904 shares of the company’s stock worth $193,000 after buying an additional 1,424 shares in the last quarter. Arthur Zaske & Associates LLC purchased a new position in Acadia Healthcare in the 3rd quarter worth approximately $283,000. CIBC World Markets Inc. purchased a new position in Acadia Healthcare in the 4th quarter worth approximately $236,000. Finally, Crossmark Global Holdings Inc. purchased a new position in Acadia Healthcare in the 3rd quarter worth approximately $441,000.
In related news, VP Randall P. Goldberg sold 960 shares of the company’s stock in a transaction on Thursday, March 1st. The shares were sold at an average price of $38.47, for a total transaction of $36,931.20. Following the completion of the sale, the vice president now directly owns 6,942 shares in the company, valued at approximately $267,058.74. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Reeve B. Waud sold 100,000 shares of the company’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $31.80, for a total transaction of $3,180,000.00. The disclosure for this sale can be found here. Insiders sold a total of 450,960 shares of company stock valued at $16,821,431 in the last ninety days. 11.10% of the stock is owned by corporate insiders.
Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, February 21st. The company reported $0.61 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.54 by $0.07. Acadia Healthcare had a net margin of 6.92% and a return on equity of 8.16%. The company had revenue of $724.50 million during the quarter, compared to analysts’ expectations of $713.20 million. During the same quarter in the prior year, the company earned $0.59 EPS. The firm’s revenue was up 3.1% on a year-over-year basis. analysts forecast that Acadia Healthcare Company Inc will post 2.45 earnings per share for the current fiscal year.
A number of research firms have commented on ACHC. Zacks Investment Research raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Monday, February 12th. Jefferies Group set a $42.00 price target on shares of Acadia Healthcare and gave the stock a “buy” rating in a research note on Tuesday, December 19th. BMO Capital Markets reissued an “outperform” rating and issued a $45.00 price target (up previously from $40.00) on shares of Acadia Healthcare in a research note on Friday, February 23rd. BidaskClub raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating in a research note on Thursday, February 22nd. Finally, Robert W. Baird reissued a “hold” rating and issued a $37.00 price target on shares of Acadia Healthcare in a research note on Friday, December 15th. Six research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $44.50.
COPYRIGHT VIOLATION WARNING: This piece was first posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another website, it was stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2018/03/13/clearline-capital-lp-invests-2-94-million-in-acadia-healthcare-company-inc-achc-stock.html.
Acadia Healthcare Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.